Oriola Oyj (HEL:ORIOLA)

Market Cap	216.00M +25.6%
Revenue (ttm)	1.85B +13.5%
Net Income	-27.10M
EPS	-0.15
Shares Out	185.25M
PE Ratio	n/a
Forward PE	12.69
Dividend	0.07 (6.07%)
Ex-Dividend Date	Apr 3, 2025

Volume	58,830
Average Volume	81,377
Open	1.170
Previous Close	1.166
Day's Range	1.166 - 1.184
52-Week Range	0.935 - 1.260
Beta	0.46
RSI	50.83
Earnings Date	Feb 25, 2026

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1907
• Employees: 801
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: ORIOLA

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.